Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.

Journal of neurology - 1 Dec 2007

Pruissen D M O, Rosendaal F R, Gorter J W, Garcia A A, Kappelle L J, Algra A

Abstract excerpt

Oral anticoagulant treatment for secondary prevention after cerebral ischaemia of presumed arterial origin is associated with a higher bleeding rate than cardioembolic stroke. This discrepancy is only partly explained by known bleeding risk factors. Haemostatic genetic variants and AB0 blood group may be involved. We performed a nested casecontrol study in patients with cerebral ischaemia of presumed arterial...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ABO Blood-Group System
Share to Anticoagulants

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Arteries

Share to Blood Proteins

Share to Brain Ischemia

Share to Fibrinogen

Share to Hemorrhage

Share to International Normalized Ratio

Source

Identifiers

PMID: 17994314
DOI: 10.1007/s00415-007-0609-5

Genes

ABO

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.PMID 17994314Read ↗

Prothrombotic genetic variants and atherosclerosis in patients with cerebral ischemia of arterial origin.Semantic proximity Read ↗

AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.Semantic proximity Read ↗

The FGA Thr312Ala polymorphism and risk of intracerebral haemorrhage in Polish and Greek populations.Semantic proximity Read ↗

Connection between genetically determined blood coagulation factors and haemorheology.Semantic proximity Read ↗

Inherited thrombophilia and stratification of ischaemic stroke risk among users of oral contraceptives.Semantic proximity Read ↗

ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation.Semantic proximity Read ↗

No evidence for an association between ABO blood group and overall ischemic stroke or any of the major etiologic subtypes.Semantic proximity Read ↗

A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases.Semantic proximity Read ↗

Prothrombotic gene polymorphisms and atherothrombotic cerebral infarction.Semantic proximity Read ↗

Association between the Thr325Ile polymorphism of the thrombin-activatable fibrinolysis inhibitor and stroke in the Ludwigshafen Risk and Cardiovascular Health Study.Semantic proximity Read ↗

Polymorphisms in prothrombotic genes and their impact on ischemic stroke in a Sardinian population.Semantic proximity Read ↗

Factor XIII-A subunit Val34Leu polymorphism in fatal atherothrombotic ischemic stroke.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.